Federated Hermes, Inc. Graybug Vision, Inc. Transaction History

Federated Hermes, Inc.

  • $43.6 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.76 - $1.25 $210 - $346
277 Added 13.18%
2,379 $3,000
Q1 2022

May 13, 2022
BUY
$1.13 - $1.93 $1,456 - $2,487
1,289 Added 158.55%
2,102 $3,000
Q4 2021

Feb 14, 2022
BUY
$1.74 - $3.6 $1,414 - $2,926
813 New
813 $1,000

Others Institutions Holding GRAY

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About GRAYBUG VISION, INC.

GRAY Quotes by TradingView
  • Ticker GRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,517,700
  • Market Cap $63.5M
  • Description
  • Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...
More about GRAY
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email